What's breaking now, across thousands of outlets.
(MedPage Today) -- Patients with MET-altered advanced non-small cell lung cancer (NSCLC) lived significantly longer with a targeted combination after progression on standard-of-care osimertinib (Tagrisso), a large randomized trial showed. Median...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Ishan Kishan had a hilarious reaction to Abhishek Sharma’s meditation celebration after the Indian batter smashed a sensational century against New Zealand on Tuesday.
The Africa International Defence Exhibition (AFRIDEX) opened yesterday at Eko Atlantic in Lagos, bringing together defence leaders, official delegations and
A study performed on 3,504 individual breast microcalcifications (MCs) scanned using high-resolution 3D micro-CT reveals that the surrounding tissue microenvironment provides stronger diagnostic…
The affected individuals comprise 51 students and two staff members. None were hospitalised.
The affected individuals comprise 51 students and two staff members. None were hospitalised.
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:
